Windward Bio Group AG WWB
As ofNov 17, 2026, 2:08 PM EST
- YTD
- -14.11%
- 1 year
- -14.11%
- Market cap
- 1.41B
- EPS (ttm)
- -0.83
- Shares out
- 58.04M
- YTD return
- -14.11%
- 1-year return
- -14.11%
- 50-day average
- 28.50
- Volume
- 176.79K
- Avg volume
- 758.35K
- Open
- 29.67
- Previous close
- 30.04
- Day's range
- 21.38 – 29.67
- 52-week range
- 18.35 – 33.99
5D +7.84 (+46.12%)
Key statistics
- 200-day average
- 28.50
- Enterprise value
- 1.47B
- Price / book
- 1.76
- Total cash
- 186.47M
- Total debt
- 474.00K
Fundamental scorecard
3 of 25 checks passed on WWB’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth No data
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
About Windward Bio Group AG
Windward Bio Group AG operates as a clinical stage biotechnology company that develops ultra-long-acting antibody medicines for patients with respiratory and dermatologic diseases. Its drug candidates WIN378, an ultra-long-acting and novel fully human monoclonal antibody, which has completed Phase I clinical study that inhibits thymic stromal lymphopoietin (TSLP); and WIN027, an ultra-long-acting bispecific antibody that is in Phase I clinical study simultaneously targets TSLP and interleukin-13 (IL-13) and two clinically validated drivers of inflammatory disease. The company has collaboration agreements with Sichuan Kelun-Biotech BioPharmaceutical Co., Ltd, Harbour BioMed (Shanghai) Co., Ltd, and Qyuns Therapeutics Co., Ltd. Windward Bio Group AG was incorporated in 2024 and is based in Basel, Switzerland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Switzerland
- Website
- windwardbio.com
News
Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aclaris Therapeutics, Summit Therapeutics And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
Windward Bio Announces Pricing of Initial Public Offering
Your note
Sign in to keep a note on WWB — it syncs with the Stock Master app.
